Category Archives: gilead sciences

Gilead Downside Targets

Gilead has the following downside targets:

Gilead Sciences Inc.

image

Nasdaq 100 Watch List: June 8, 2012

Below are the Nasdaq 100 companies that are within 10% of their respective 52-week lows. Stocks that appear on our watch lists are not recommendations to buy. Instead, they are the starting point for doing your research and determining the best company to buy. Ideally, a stock that is purchased from this list is done after a considerable decline in the price and rigorous due diligence.

symbol Name Price P/E EPS Yield P/B % from Low
SYMC Symantec Corporation 14.57 9.28 1.57 - 2.06 2.17%
DELL Dell Inc. 12.12 6.92 1.75 - 2.28 2.71%
CHRW CH Robinson Worldwide Inc. 57.92 21.6 2.68 2.3 7.51 3.65%
EA Electronic Arts Inc. 13.47 58.57 0.23 - 1.75 4.74%
INFY Infosys Ltd. 43.62 14.54 3 1.3 3.81 5.36%
NVDA NVIDIA Corporation 12.12 14.8 0.82 - 1.72 5.67%
GMCR Green Mountain Coffee Roasters 23.13 11.11 2.08 - 1.76 6.25%
EXPD Expeditors Int'l of WA 39.36 22.75 1.73 1.4 3.95 6.49%
CTRP Ctrip.com Int'l 18.66 17.86 1.04 0 2.38 6.63%
SPLS Staples, Inc. 12.86 9.23 1.39 3.4 1.24 7.71%
LRCX Lam Research 37.62 16.65 2.26 - 1.72 8.07%
NFLX Netflix, Inc. 65.64 22.22 2.95 - 5.41 8.14%
WYNN Wynn Resorts Ltd. 104.21 22.1 4.72 1.9 46.53 8.76%
NTAP NetApp, Inc. 30.33 19.2 1.58 - 2.65 9.14%
MCHP Microchip Technology Inc. 32.01 19.4 1.65 4.4 3.08 9.25%
VOD Vodafone Group 26.58 12.6 2.11 7.5 1.1 9.34%
MRVL Marvell Technology 12.28 13.15 0.93 2 1.4 9.35%
ORCL Oracle Corporation 27.16 14.23 1.91 0.9 3.16 9.87%
CTSH Cognizant 58.85 19.81 2.97 - 4.14 9.92%

Watch List Summary

Of interest on our watch list is NVIDIA (NVDA).  According to Yahoo!Finance, “NVIDIA Corporation provides graphics chips for use in smartphones, personal computers (PC), tablets, and professional workstations markets worldwide.”  As we’ve described in the past, we have a strong interest in chip sector stocks and believe that the long-term prospects for companies in the chip industry is very appealing.

NVDA first appeared on our watch list on June 12, 2010.  At that time, NVDA was trading at $11.61.  By February 18, 2011, NVDA was trading as high as $25.68 which was a gain of over +120%.  We’re not certain that NVDA’s decline has ended.  According to Edson Gould’s Speed Resistance Lines, NVDA has already declined below the conservative downside target of $17.87 based on the February 2011 high.  The persistence of the current decline suggests that the stock could decline to the extreme downside target of $8.67.  We’re doing everything we can to hold off buying this stock at the current time.

image

Watch List Performance Review

The following is a performance review of the top five Nasdaq 100 Watch List from June 4, 2010.  Keep in mind that this is a 2 year performance review instead of a 1 year review.

Symbol
Name 2010 2012 % change
GILD Gilead Sciences, Inc. $34.71 49.21 41.77%
SYMC Symantec Corporation $13.92 14.43 3.66%
ERTS Electronic Arts Inc. $15.81 13.07 -17.33%
APOL Apollo Group, Inc. $51.48 32.42 -37.02%
QCOM QUALCOMM $35.30 55.85 58.22%
average 9.86%
NDX Nasdaq 100 1,832.04 2,478.13 35.27%

As can you can see, the list of top five stocks significantly underperformed the Nasdaq 100 (NDX), mainly due to Apple Inc. (AAPL) having an outsized impact on the index.  However, underneath the static 2-year performance data is a story to be told, which is the basis of our New Low investment strategy.

In the chart below, take note of the period around July 2011.  At that time, Qualcomm had gains of +60%, Electronic Arts had gains of +55%, Symantec had gains of +42% and Gilead Sciences had gains of +21%.  Only Apollo Group had losses to compare against the other stocks.

image

In the case of Symantec and Electronic Arts, they have come full circle after a 2-year period. This cycle is not unusual for most of the stocks that we track. Even when the stock does not approach the prior low of a watch list, many stocks attain a 52-week low after 2 to 2.5 years (as in the NVDA example above). Be on the lookout for stocks that have similar cycles like EA, SYMC and NVDA since their ability to replicated such moves adds to the prospect that they could pull a repeat performance.

Investment Observation: Gilead Sciences (GILD) at $45.52

In my August 3o, 2009 article titled "Reviewing the Stock Analysts," I pointed out a book that I felt would advance your ability to analyzing individual stocks much better than whatever method that you might be using. In the article that I posted on August 30th, I stated that I'm convinced that if you buy the book Quest For Value you would have made a wise investment.

The only reason that I'm convinced that Quest For Value is useful is due to the third party examination of the performance of the approach as applied by Matrix USA. On a consistent basis, the economic value added (EVA) method was attributable to Matrix USA beating all other stock analysts for buying and selling stocks.

Now, in the most recent issue of Fortune Magazine dated January 18, 2010, Geoff Colvin reiterates that using the economic value added (EVA) approach is resoundingly effective at discerning quality stocks without the ability of corporations to tweak or fudge the financials through generally accepted accounting principles.

The punchline to the Colvin article is that of the three top quality companies based on the EVA model, Gilead Sciences (GILD) is among them. GILD happens to be one of the Nasdaq 100 companies on our most recent watch list. On October 23, 2009, I indicated that based on the Coppock Curve, GILD would be among the best companies to investigate for a potential purchase. I am reiterating the belief that GILD is worthy of investigating since it has not varied by much since my last look at the company. -Touc

related articles: